<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Although metabolic and electrolyte derangements, especially in thalamocortical pathways, secondary to COVID-19 are plausible causes of clinical or subclinical acute symptomatic seizures and status epilepticus [
 <xref ref-type="bibr" rid="CR16">16</xref>], Lu L. et al [
 <xref ref-type="bibr" rid="CR17">17</xref>] concluded that neither the virus nor potential risk factors for seizures increased the likelihood of acute symptomatic seizures in COVID-19.
</p>
